With $100 million under management, Hamilton BioVentures focuses on investing in talented entrepreneurs who are bringing new Life Science technology enterprises to market. Their investments primarily take the form of direct equity in early-stage companies located on the West Coast, particularly those developing biopharmaceuticals and medical devices for major human diseases and medical conditions.